USNA

USANA Health Sciences, Inc.

Price Chart

Latest Quote

$14.21

-0.05 (-0.33%)

Current Price

Previous Close	$14.26
Open	$14.19
Day High	$14.36
Day Low	$14.10
Volume	6,901

Fetched: 2026-09-01T14:03:16

Stock Information

Shares Outstanding	18.48M
Cash Equivalents	$168.56M
Revenue	$913.36M
Net Income	$-22.16M
Sector	Consumer Defensive
Industry	Packaged Foods
Market Cap	$262.60M
EPS (TTM)	$-1.18
Exchange	NYQ

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$135.52M
Sales	$913.36M
Income	$-22.16M
Book/sh	$28.51
Cash/sh	$9.12
Employees	2K

Financial Ratios

Quick Ratio	1.63
Current Ratio	2.66

Returns & Margins

ROA	3.61%
ROE	-5.06%
Gross Margin	77.45%
Operating Margin	4.09%
Profit Margin	-2.43%

Ownership

Insider Ownership	40.88%
Institutional Ownership	63.18%
Insider & Institutional transactions data not available

Valuation Ratios

Forward P/E	8.03
PEG	1.07
P/S	0.29
P/B	0.50

Analyst Data

Recommendation	none
Target Price	$25.00

Technical Indicators

SMA20	$14.32
SMA50	$18.69
SMA200	$19.21
RSI	57.84
ATR	0.5893

Shares Float	9.93M
Short Float	6.91%
Short Ratio	4.15
Volatility	0.72
Rel Volume	0.03

Performance History

Week	+4.66%
Month	-35.72%
Quarter	-22.46%
6 Months	-29.26%
YTD	-26.89%
Year	-54.71%
3 Years	-77.65%
5 Years	-85.22%
10 Years	-79.15%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-09-01	$14.21	6,901
2026-08-31	$14.26	333,400
2026-08-27	$14.10	162,800
2026-08-26	$13.67	185,600
2026-08-25	$13.78	139,400
2026-08-24	$13.58	197,400
2026-08-21	$13.55	148,800
2026-08-20	$13.18	211,000
2026-08-19	$13.25	232,700
2026-08-18	$13.21	268,400
2026-08-17	$12.86	242,100
2026-08-14	$13.37	194,500
2026-08-13	$13.63	262,500
2026-08-12	$13.54	291,100
2026-08-11	$13.76	345,200
2026-08-10	$14.34	296,700
2026-08-07	$15.47	236,200
2026-08-06	$14.89	559,000
2026-08-05	$14.99	688,700
2026-08-04	$22.78	126,000
2026-08-03	$22.84	112,200

About USANA Health Sciences, Inc.

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

📰 Latest News

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Reconciled Cost Of Revenue	$200,852,000	$161,212,000	$176,693,000	$193,890,000
Cost Of Revenue	$200,852,000	$161,212,000	$176,693,000	$193,890,000
Total Revenue	$925,257,000	$854,503,000	$921,010,000	$998,601,000
Operating Revenue	$925,257,000	$854,503,000	$921,010,000	$998,601,000
Expenses
Interest Expense	$842,000	$281,000	$262,000	$192,000
Total Expenses	$874,395,000	$788,179,000	$827,939,000	$890,987,000
Other Income Expense	$-10,908,000	$-1,011,000	$7,000	$-2,590,000
Other Non Operating Income Expenses	$2,522,000	$-1,011,000	$7,000	$-2,590,000
Net Non Operating Interest Income Expense	$1,573,000	$11,038,000	$9,375,000	$3,597,000
Interest Expense Non Operating	$842,000	$281,000	$262,000	$192,000
Operating Expense	$673,543,000	$626,967,000	$651,246,000	$697,097,000
Other Operating Expenses	$336,171,000	$363,699,000	$394,257,000	$434,793,000
General And Administrative Expense	$337,372,000	$263,268,000	$256,989,000	$262,304,000
Selling And Marketing Expense	-	-	$394,257,000	$434,793,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$10,760,000	$42,030,000	$63,788,000	$69,350,000
Net Interest Income	$1,573,000	$11,038,000	$9,375,000	$3,597,000
Interest Income	$2,415,000	$11,319,000	$9,637,000	$3,789,000
Normalized Income	$18,818,000	$42,030,000	$63,788,000	$69,350,000
Net Income From Continuing And Discontinued Operation	$10,760,000	$42,030,000	$63,788,000	$69,350,000
Total Operating Income As Reported	$37,432,000	$66,324,000	$93,071,000	$107,614,000
Net Income Common Stockholders	$10,760,000	$42,030,000	$63,788,000	$69,350,000
Net Income	$10,760,000	$42,030,000	$63,788,000	$69,350,000
Net Income Including Noncontrolling Interests	$11,477,000	$42,060,000	$63,788,000	$69,350,000
Net Income Continuous Operations	$11,477,000	$42,060,000	$63,788,000	$69,350,000
Pretax Income	$41,527,000	$76,351,000	$102,453,000	$108,621,000
Special Income Charges	$-13,430,000	-	-	-
Interest Income Non Operating	$2,415,000	$11,319,000	$9,637,000	$3,789,000
Operating Income	$50,862,000	$66,324,000	$93,071,000	$107,614,000
Gross Profit	$724,405,000	$693,291,000	$744,317,000	$804,711,000
Per Share
Diluted EPS	$0.58	$2.19	$3.30	$3.59
Basic EPS	$0.59	$2.21	$3.33	$3.61
Other
Tax Effect Of Unusual Items	$-5,372,000	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$95,501,000	$98,861,000	$123,110,000	$130,223,000
Total Unusual Items	$-13,430,000	-	-	-
Total Unusual Items Excluding Goodwill	$-13,430,000	-	-	-
Reconciled Depreciation	$39,702,000	$22,229,000	$20,395,000	$21,410,000
EBITDA (Bullshit earnings)	$82,071,000	$98,861,000	$123,110,000	$130,223,000
EBIT	$42,369,000	$76,632,000	$102,715,000	$108,813,000
Diluted Average Shares	$18,574,000	$19,162,000	$19,345,000	$19,310,000
Basic Average Shares	$18,280,857	$19,064,000	$19,130,000	$19,206,000
Diluted NI Availto Com Stockholders	$10,760,000	$42,030,000	$63,788,000	$69,350,000
Minority Interests	$-717,000	$-30,000	$0	-
Tax Provision	$30,050,000	$34,291,000	$38,665,000	$39,271,000
Other Special Charges	$6,463,000	-	-	-
Impairment Of Capital Assets	$6,967,000	-	-	-
Selling General And Administration	$337,372,000	$263,268,000	$256,989,000	$262,304,000
Other Gand A	$337,372,000	$263,268,000	$256,989,000	$262,304,000

Fetched: 2026-08-15

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$261,991,000	$236,118,000	$450,181,000	$384,672,000
Total Assets	$742,915,000	$748,193,000	$632,757,000	$596,549,000
Total Non Current Assets	$454,510,000	$469,006,000	$215,011,000	$212,167,000
Other Non Current Assets	$61,805,000	$58,806,000	$54,892,000	$54,795,000
Non Current Deferred Assets	$27,209,000	$19,644,000	$13,284,000	$9,799,000
Non Current Deferred Taxes Assets	$27,209,000	$19,644,000	$13,284,000	$9,799,000
Goodwill And Other Intangible Assets	$271,113,000	$295,991,000	$47,021,000	$49,800,000
Other Intangible Assets	$133,151,000	$151,823,000	$29,919,000	$32,432,000
Current Assets	$288,405,000	$279,187,000	$417,746,000	$384,382,000
Other Current Assets	$4,853,000	$4,808,000	$6,096,000	$7,121,000
Current Deferred Assets	$914,000	$894,000	$1,181,000	$3,157,000
Prepaid Assets	$12,545,000	$13,759,000	$11,394,000	$11,382,000
Inventory	$102,608,000	$69,735,000	$61,454,000	$67,089,000
Receivables	$9,105,000	$8,223,000	$7,201,000	$7,213,000
Other Receivables	$8,089,000	$7,419,000	$6,172,000	$5,183,000
Taxes Receivable	$1,016,000	$804,000	$1,029,000	$2,030,000
Cash Cash Equivalents And Short Term Investments	$158,380,000	$181,768,000	$330,420,000	$288,420,000
Cash And Cash Equivalents	$158,380,000	$181,768,000	$330,420,000	$288,420,000
Debt
Total Debt	$19,650,000	$29,013,000	$8,064,000	$6,892,000
Current Debt And Capital Lease Obligation	$19,650,000	$29,013,000	$8,064,000	$6,892,000
Current Debt	$14,000,000	$23,000,000	$786,000	-
Liabilities
Total Liabilities Net Minority Interest	$156,643,000	$161,861,000	$135,555,000	$162,077,000
Total Non Current Liabilities Net Minority Interest	$28,078,000	$22,236,000	$16,710,000	$18,244,000
Other Non Current Liabilities	$23,186,000	$18,163,000	$12,158,000	$14,173,000
Non Current Deferred Liabilities	$4,892,000	$4,073,000	$4,552,000	$4,071,000
Non Current Deferred Taxes Liabilities	$4,892,000	$4,073,000	$4,552,000	$4,071,000
Current Liabilities	$128,565,000	$139,625,000	$118,845,000	$143,833,000
Other Current Liabilities	$39,548,000	$45,414,000	$48,325,000	$71,476,000
Current Deferred Liabilities	$10,640,000	$12,050,000	$13,910,000	$20,875,000
Payables And Accrued Expenses	$38,079,000	$37,312,000	$32,348,000	$27,256,000
Payables	$28,579,000	$23,743,000	$22,598,000	$27,256,000
Total Tax Payable	$11,316,000	$11,759,000	$12,528,000	$16,207,000
Income Tax Payable	$3,369,000	$3,710,000	$3,297,000	$4,973,000
Accounts Payable	$17,263,000	$11,984,000	$10,070,000	$11,049,000
Equity
Common Stock Equity	$533,104,000	$532,109,000	$497,202,000	$434,472,000
Total Equity Gross Minority Interest	$586,272,000	$586,332,000	$497,202,000	$434,472,000
Stockholders Equity	$533,104,000	$532,109,000	$497,202,000	$434,472,000
Gains Losses Not Affecting Retained Earnings	$-16,178,000	$-22,670,000	$-13,695,000	$-12,787,000
Other Equity Adjustments	$-16,178,000	$-22,670,000	$-13,695,000	$-12,787,000
Retained Earnings	$465,720,000	$478,944,000	$445,217,000	$391,636,000
Other
Ordinary Shares Number	$18,280,857	$19,064,000	$19,130,000	$19,206,000
Share Issued	$18,280,857	$19,064,000	$19,130,000	$19,206,000
Tangible Book Value	$261,991,000	$236,118,000	$450,181,000	$384,672,000
Invested Capital	$547,104,000	$555,109,000	$497,988,000	$434,472,000
Working Capital	$159,840,000	$139,562,000	$298,901,000	$240,549,000
Capital Lease Obligations	$5,650,000	$6,013,000	$7,278,000	$6,892,000
Total Capitalization	$533,104,000	$532,109,000	$497,202,000	$434,472,000
Minority Interest	$53,168,000	$54,223,000	$0	-
Additional Paid In Capital	$83,544,000	$75,816,000	$65,661,000	$55,604,000
Capital Stock	$18,000	$19,000	$19,000	$19,000
Common Stock	$18,000	$19,000	$19,000	$19,000
Current Deferred Revenue	$10,640,000	$12,050,000	$13,910,000	$20,875,000
Current Capital Lease Obligation	$5,650,000	$6,013,000	$7,278,000	$6,892,000
Line Of Credit	$14,000,000	$23,000,000	$786,000	$0
Pensionand Other Post Retirement Benefit Plans Current	$20,648,000	$15,836,000	$16,198,000	$17,334,000
Current Accrued Expenses	$9,500,000	$13,569,000	$9,750,000	-
Goodwill	$137,962,000	$144,168,000	$17,102,000	$17,368,000
Net PPE	$94,383,000	$94,565,000	$99,814,000	$97,773,000
Accumulated Depreciation	$-134,578,000	$-130,088,000	$-128,939,000	$-124,748,000
Gross PPE	$228,961,000	$224,653,000	$228,753,000	$222,521,000
Leases	$10,839,000	$12,611,000	$14,337,000	$14,388,000
Construction In Progress	$5,798,000	$4,620,000	$9,807,000	$6,081,000
Other Properties	$55,387,000	$53,981,000	$54,502,000	$50,679,000
Machinery Furniture Equipment	$68,428,000	$67,183,000	$62,321,000	$63,308,000
Buildings And Improvements	$78,585,000	$76,677,000	$77,803,000	$78,071,000
Land And Improvements	$9,924,000	$9,581,000	$9,983,000	$9,994,000
Properties	$0	$0	$0	$0
Finished Goods	$65,873,000	$41,663,000	$36,899,000	$41,028,000
Work In Process	$5,003,000	$3,612,000	$4,707,000	$4,285,000
Raw Materials	$31,732,000	$24,460,000	$19,848,000	$21,776,000

Fetched: 2026-08-15

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$8,526,000	$50,919,000	$56,147,000	$93,502,000
Operating Activities
Operating Cash Flow	$22,349,000	$60,992,000	$70,641,000	$103,902,000
Cash Flow From Continuing Operating Activities	$22,349,000	$60,992,000	$70,641,000	$103,902,000
Operating Gains Losses	$-2,093,000	$1,000	$10,000	$141,000
Investing Activities
Capital Expenditure	$-13,823,000	$-10,073,000	$-14,494,000	$-10,400,000
Investing Cash Flow	$-10,125,000	$-213,090,000	$-11,975,000	$-12,370,000
Cash Flow From Continuing Investing Activities	$-10,125,000	$-213,090,000	$-11,975,000	$-12,370,000
Net Other Investing Changes	-	-	-	-
Financing Activities
Repurchase Of Capital Stock	$-27,507,000	$-9,444,000	$-11,599,000	$-25,382,000
Financing Cash Flow	$-40,603,000	$9,553,000	$-14,237,000	$-30,088,000
Cash Flow From Continuing Financing Activities	$-40,603,000	$9,553,000	$-14,237,000	$-30,088,000
Net Other Financing Charges	$-4,096,000	$-3,223,000	$-3,430,000	$-4,706,000
Net Common Stock Issuance	$-27,507,000	$-9,444,000	$-11,599,000	$-25,382,000
Other
Repayment Of Debt	$-26,600,000	$-1,467,000	$-750,000	$-11,000,000
Issuance Of Debt	$17,600,000	$23,687,000	$1,542,000	$11,000,000
Interest Paid Supplemental Data	$663,000	$76,000	$68,000	$49,000
End Cash Position	$161,240,000	$184,508,000	$333,246,000	$291,320,000
Beginning Cash Position	$184,508,000	$333,246,000	$291,320,000	$243,653,000
Effect Of Exchange Rate Changes	$5,111,000	$-6,193,000	$-2,503,000	$-13,777,000
Changes In Cash	$-28,379,000	$-142,545,000	$44,429,000	$61,444,000
Common Stock Payments	$-27,507,000	$-9,444,000	$-11,599,000	$-25,382,000
Net Issuance Payments Of Debt	$-9,000,000	$22,220,000	$792,000	$0
Net Short Term Debt Issuance	$-9,000,000	$22,220,000	$792,000	$0
Short Term Debt Payments	$-26,600,000	$-1,467,000	$-750,000	$-11,000,000
Short Term Debt Issuance	$17,600,000	$23,687,000	$1,542,000	$11,000,000
Net Investment Purchase And Sale	$-1,072,000	$255,000	$2,504,000	$4,555,000
Sale Of Investment	$0	$1,125,000	$3,775,000	$4,555,000
Purchase Of Investment	$-1,072,000	$-870,000	$-1,271,000	$0
Net Business Purchase And Sale	$865,000	$-203,336,000	$0	$-6,532,000
Sale Of Business	$865,000	$0	$0	-
Purchase Of Business	$0	$-203,336,000	$0	$-6,532,000
Net PPE Purchase And Sale	$-9,918,000	$-10,009,000	$-14,479,000	$-10,393,000
Sale Of PPE	$3,905,000	$64,000	$15,000	$7,000
Purchase Of PPE	$-13,823,000	$-10,073,000	$-14,494,000	$-10,400,000
Change In Working Capital	$-43,078,000	$-13,003,000	$-27,999,000	$771,000
Change In Other Current Liabilities	$-14,218,000	$-6,745,000	$-30,034,000	$-9,066,000
Change In Payables And Accrued Expense	$5,204,000	$-1,269,000	$-428,000	$-2,656,000
Change In Payable	$5,204,000	$-1,269,000	$-428,000	$-2,656,000
Change In Account Payable	$5,204,000	$-1,269,000	$-428,000	$-2,656,000
Change In Prepaid Assets	$621,000	$-2,871,000	$110,000	$-3,304,000
Change In Inventory	$-34,685,000	$-2,118,000	$2,353,000	$15,797,000
Stock Based Compensation	$13,828,000	$14,558,000	$14,595,000	$13,331,000
Asset Impairment Charge	$9,646,000	$1,891,000	$2,601,000	$6,082,000
Deferred Tax	$-7,133,000	$-6,744,000	$-2,749,000	$-7,183,000
Deferred Income Tax	$-7,133,000	$-6,744,000	$-2,749,000	$-7,183,000
Depreciation Amortization Depletion	$39,702,000	$22,229,000	$20,395,000	$21,410,000
Depreciation And Amortization	$39,702,000	$22,229,000	$20,395,000	$21,410,000
Depreciation	$39,702,000	$22,229,000	$20,395,000	$21,410,000
Gain Loss On Sale Of PPE	$-2,093,000	$1,000	$10,000	$141,000
Net Income From Continuing Operations	$11,477,000	$42,060,000	$63,788,000	$69,350,000
Income Tax Paid Supplemental Data	-	$40,470,000	$44,247,000	$45,863,000

Fetched: 2026-08-15

USNA

Price Chart

Latest Quote

$14.21

Stock Information

📊 Comprehensive Analysis

Company Data

Financial Ratios

Returns & Margins

Ownership

Valuation Ratios

Analyst Data

Technical Indicators

Performance History

Recent Price History

About USANA Health Sciences, Inc.

📰 Latest News

3 Reasons to Sell USNA and 1 Stock to Buy Instead

Reflecting On Personal Care Stocks’ Q2 Earnings: USANA (NYSE:USNA)

1 Consumer Stock for Long-Term Investors and 2 We Question

1 Oversold Stock Set for a Comeback and 2 We Avoid

3 Small-Cap Stocks We Find Risky

5 Must-Read Analyst Questions From USANA’s Q2 Earnings Call

USANA (USNA) Q2 2026 Earnings Call Transcript

3 Russell 2000 Stocks We Find Risky

Why Usana Health Sciences Stock Plummeted This Week

USANA Health Sciences Q2 Earnings Call Highlights

Income Statement (Annual)

Balance Sheet (Annual)

Cash Flow Statement (Annual)